Introduction Fujian Haixi Pharmaceutical Co., Ltd. is a leading asset-light pharmaceutical company, operating as a Market Authorization Holder (MAH) without manufacturing facilities. Since its inception in Fuzhou in 2012, Haixi Pharma has charted a unique course among start-up pharma ventures. The company prioritizes the development of small-molecule innovative drugs with clear clinical needs and global market potential and concentrates on first-to-market generics, complex generics, and high-quality generic drugs. |